Target intelligence / Profile preview

E3 ubiquitin-protein ligase TRIM4 (TRIM4)

Target
TRIM4
Molecular classification
Enzyme, E3 ubiquitin-protein ligase, Tripartite motif family (TRIM protein), RING finger protein
01

Overview

E3 ubiquitin-protein ligase TRIM4 (TRIM4) is a cytoplasmic enzyme belonging to the tripartite motif (TRIM) family of proteins, defined by its RING domain, two B-box domains, and a coiled-coil region[3]. TRIM4 acts as an E3 ubiquitin ligase, mediating the transfer of ubiquitin to specific substrate proteins, particularly influencing immune signaling pathways such as the RIG-I-dependent antiviral response through K63-linked ubiquitination of CARD domain-containing substrates[1][3]. TRIM4 has been associated with regulation of mitochondrial organization, cellular response to oxidative stress, and promotion of cell death under certain conditions[2]. Its expression is implicated in cancer biology, especially as a prognostic biomarker in hepatocellular carcinoma where decreased TRIM4 expression correlates with worse prognosis and higher recurrence risk[2]. No approved drugs directly targeting TRIM4 are currently known, and there are no specific safety concerns reported unique to its modulation.

Other names
Tripartite motif-containing protein 4RNF87RING finger protein 87RING-type E3 ubiquitin transferase TRIM4tripartite motif protein TRIM4
02

Mechanism of action

Ubiquitin-mediated protein degradation, Regulation of antiviral signaling via K63-linked ubiquitination, Sensitization to oxidative cell death

03

Biological functions

UbiquitinationImmune responseAntiviral signalingCell deathMitochondrial regulation
04

Disease associations

Cancer (notably hepatocellular carcinoma)Infection (viral)Other (inflammation, apoptosis)
05

Biomarkers

TRIM4 protein expression (prognostic for hepatocellular carcinoma)

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase TRIM4 (TRIM4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase TRIM4 (TRIM4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call